Hot-selling Lilly drug gets OK for second use
Taltz, launched in 2016 to treat plaque psoriasis, won approval from the Food and Drug Administration for a second indication—treating adults with a form of arthritis.
Health Care Businesses
Articles
Former Indiana doctor sentenced to probation in ‘pill mill’ case
The former doctor, who ran offices in Peru, Bloomington and Indianapolis, was sentenced to more than 10 years of probation but no time behind bars under a plea agreement with prosecutors. Fifty of the 55 charges against him were dropped.
Lawsuit accuses Lilly of using kickbacks to boost insulin sales
A recently unsealed suit accuses the Indianapolis-based drugmaker of offering free nursing services to doctors to induce them to prescribe the company’s products.
Cook Group set to start expansion project in old refrigerator plant
Medical-device maker Cook Group expects to start work in December on an expansion project as it takes over a former General Electric refrigerator factory in Bloomington.
Trump’s HHS nominee reaped big earnings from drug industry tenure
As a top pharma industry veteran from 2007 to 2017, former Eli Lilly and Co. executive Alex Azar built a substantial financial portfolio now worth as much as $20.6 million.
Maker of opioid treatment planning Indy-area expansion
Innovative Health Solutions Inc. recently received FDA approval for a device that treats opioid withdrawal symptoms.
IU Health loses, recovers patient info in Muncie
The Indianapolis-based health system said Nov. 3 that it recovered the bag of paperwork within hours and began an internal investigation.
The agony and ecstasy of electronic medical records
Health care providers’ frustration is running high, and even advocates say the movement has fallen short.
Trump names former Lilly exec as new health secretary
If confirmed by the Senate, former Eli Lilly and Co. exec Alex Azar will oversee a $1 trillion department responsible for major health insurance programs, medical research, food and drug safety, and public health.
Cook Medical wins first trial over blood-clot filters
Nearly 3,000 people have sued the Bloomington-based device maker, claiming the filters malfunctioned, sometimes piercing organs.
Trump expected to name ex-Lilly exec to lead Health & Human Services
Alex Azar, who ran U.S. operations for Eli Lilly before leaving in January, would be the administration’s point person on running—or dismantling—Obamacare.
Carmel software firm in midst of expansion, 40 hires
Clinical Architecture is spending $4.2 million on its new headquarters space while seeking software developers, clinical experts, salespeople and product managers.
West Lafayette biotech raises $40M to develop cancer-imaging drugs
The company said the funds would help it test its lead compound in late-stage clinical trials, allowing surgeons to detect cancerous cells with the help of fluorescent dyes.
IU Health pushes further into Fort Wayne, a market in upheaval
The Indianapolis-based health system said it will open a primary-care medical office in Fort Wayne early next year, and is examining “a long-term presence” in the market.
Study: Premiums for popular Obamacare plan up 34 percent
Premiums for the most popular Obamacare plans are going up an average of 34 percent nationwide, according to a new study. But the increases aren’t as high in Indiana.
Lilly shares slide on news of possible sale, spinoff of Elanco
Despite slipping sales and lost market share, the Elanco animal-health unit is strong and the time is right to explore selling or spinning it off, Eli Lilly and Co. officials said Tuesday.
Lilly plans $72M upgrade for Indianapolis insulin operation
The Indianapolis drugmaker said it will use the money to replace an existing line that fills vials for Humalog and Humulin and to prepare for new insulin products.
Device maker SonarMed ponders whether to go solo or find a partner
The Carmel-based company makes a device that uses sound waves to help position and monitor breathing tubes for newborns in hospitals.
Trump considers former Lilly exec for HHS post
Before joining Eli Lilly and Co., Alex Azar served as the general counsel and deputy secretary of Health and Human Services Administration under President George Bush.
Legal fight looms over California’s new drug pricing law
California has passed a law requiring pharmaceutical companies to explain their price increases, escalating the state-by-state battle between lawmakers trying to bring more transparency to the industry’s practices and drugmakers that oppose the efforts.